Definitive Surgical Resection: Clinical Trials

4 trials of Definitive Surgical Resection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting, 1 terminated. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Terminated 1
Not applicable1Recruiting 1
Phase 11Active not recruiting 1

Follow Definitive Surgical Resection: new trials by email Literature Review of Definitive Surgical Resection trials Research Report on Definitive Surgical Resection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant RP2 + Nivolumab in Patients With Melanoma
RP2 (vusolimogene oderparepvec), Nivolumab, Definitive Surgical Resection - MelanomaCutaneous Melanoma Resectable, Melanoma
Phase 2Not yet recruitingYana Najjar342026-12-312026-10-07
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Biospecimen Collection, Chemotherapy, Computed Tomography - Ewing Sarcoma, Round Cell Sarcoma With EWSR1-non-ETS Fusion
Not applicableRecruitingMayo Clinic1702025-12-052026-10-06
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
Definitive Surgical Resection, Nanoplexed Poly I:C BO-112, Nivolumab - Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor
Phase 1Active not recruitingJonsson Comprehensive Cancer Center142020-10-142026-03-10
Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer
Carboplatin, Chemoradiotherapy, Cisplatin - Locally Advanced Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma
Phase 2TerminatedM.D. Anderson Cancer Center312008-06-162026-07-17

Conditions studied

Dermatofibrosarcoma (1)  ·  Histiocytoma, Malignant Fibrous (1)  ·  Leiomyosarcoma (1)  ·  Melanoma (1)  ·  Neurofibrosarcoma (1)  ·  Paranasal Sinus Neoplasms (1)  ·  Retinitis Pigmentosa 2 (1)  ·  Sarcoma (1)  ·  Sarcoma, Ewing (1)  ·  Sarcoma, Synovial (1)  ·  Sinonasal undifferentiated carcinoma (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Yana Najjar (1)

Countries

United States (4)

Top investigators

Ehab Y Hanna (1)  ·  Roman O. Kowalchuk, MD (1)  ·  Vishruth Reddy, MD, PhD (1)

NIH funding

K08CA245181 (1)